Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: A controlled clinical trial

Journal of Periodontology

Volumn 83, Issue 3, 2012, Pages 267-278

  López, Néstor J ^a   Quintero, Antonio ^b   Casanova, Patricia A ^a   Ibieta, Carola I ^c   Baelum, Vibeke ^d   Lópezi, Rodrigo ^d  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE LOS ANDES   (Chile)

^c University of Development   (Chile)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

C reactive protein; Controlled clinical trial; Inflammation; Metabolic syndrome X; Obesity; Periodontitis

Indexed keywords

EID: 84857865945     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110227     Document Type: Article

References (51)

1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999;340:115-126.
2. Beck JD, Offenbacher S. Systemic effects of periodontitis: Epidemiology of periodontal disease and cardiovascular disease. J Periodontol 2005;76:2089-2100. (Pubitemid 41748958)
3. Ebersole JL, Machen RL, Steffen MJ, Willmann DE. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997;107:347-352. (Pubitemid 27049263)
4. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, Van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000;71: 1528-1534.
5. Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT. Examination of the relation between periodontal health status and cardiovascular risk factors: Serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol 2000;151:273-282. (Pubitemid 30463632)
6. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: Results from a randomized controlled clinical trial. Am Heart J 2006;151:977-984.
7. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
8. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28:629-636. (Pubitemid 351651324)
9. D'Aiuto F, Sabbah W, Netuveli G, et al. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab 2008;93:3989-3994.
10. Nibali L, D'Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: A casecontrol study. J Clin Periodontol 2007;34:931-937.
11. Li P, He L, Sha YQ, Luan QX. Relationship of metabolic syndrome to chronic periodontitis. J Periodontol 2009; 80:541-549.
12. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001;285:2481-2485. (Pubitemid 32433842)
13. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: Findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003;168:351-358. (Pubitemid 36703335)
14. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De NE. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001; 72:1221-1227. (Pubitemid 33607184)
15. Janket SJ, Jones JA, Meurman JH, Baird AE, Van Dyke TE. Oral infection, hyperglycemia, and endothelial dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:173-179.
16. D'Aiuto F, Parkar M, Andreou G, et al. Periodontitis and systemic inflammation: Control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004;83:156-160. (Pubitemid 41713801)
17. Tonetti MS, D'Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007;356:911-920. (Pubitemid 46339910)
18. Yamazaki K, Honda T, Oda T, et al. Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 2005;40:53-58. (Pubitemid 40186627)
19. Behle JH, Sedaghatfar MH, Demmer RT, et al. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 2009;36:287-294.
20. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35: 277-290.
21. Ioannidou E, Malekzadeh T, Dongari-Bagtzoglou A. Effect of periodontal treatment on serum C-reactive protein levels: A systematic review and meta-analysis. J Periodontol 2006;77:1635-1642. (Pubitemid 44680225)
22. Montebugnoli L, Servidio D, Miaton RA, et al. Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease. J Clin Periodontol 2005;32:188-192. (Pubitemid 40341854)
23. Offenbacher S, Beck JD, Moss K, et al. Results from the Periodontitis and Vascular Events (PAVE) Study: A pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 2009;80:190-201.
24. Tuter G, Kurtis B, Serdar M, et al. Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease. J Clin Periodontol 2007;34: 673-681.
25. Grundy SM, Brewer B, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 2004;109:433-438. (Pubitemid 38133916)
26. Lopez NJ, Smith PC, Gutiérrez J. Periodontal therapy may reduce the risk of preterm low birth weight in women with periodontal disease: A randomized controlled trial. J Periodontol 2002;73:911-924. (Pubitemid 34965825)
27. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103-115.
28. Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol 2007;34:243-253.
29. Haffajee AD, Teles RP, Socransky SS. The effect of periodontal therapy on the composition of the subgingival microbiota. Periodontol 2000 2006;42:219-258. (Pubitemid 44286052)
30. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957;17: 237-246.
31. Chakraborty H, Gu H. A mixed model approach for intent-to-treat analysis in longitudinal clinical trials with missing values. Available from: RTI International, Research Triangle Park, NC; http://www.rti.org/pubs/mr- 0009-0904-chakraborty.pdf. Accessed March 26, 2011.
32. Smulow JB, Turesky SS, Hill RG. The effect of supragingival plaque removal on anaerobic bacteria deep periodontal pockets. J Am Dent Assoc 1983;107: 737-742.
33. Westfelt E, Rylander H, Dahlen G, Lindhe J. The effect of supragingival plaque control on the progression of advanced periodontal disease. J Clin Periodontol 1998;25:536-541. (Pubitemid 128705908)
34. Axelsson P, Lindhe J. Effect of controlled oral hygiene procedures on caries and periodontal disease in adults. J Clin Periodontol 1978;5:133-151. (Pubitemid 8360956)
35. McNabb H, Mombelli A, Lang NP. Supragingival cleaning 3 times a week. The microbiological effects in moderately deep pockets. J Clin Periodontol 1992; 19:348-356.
36. Yudkin JS, Juhan-Vague I, Hawe E, et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: The HIFMECH study. Metabolism 2004;53: 852-857. (Pubitemid 38829457)
37. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005;84:269-273. (Pubitemid 43822036)
38. Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol 2003; 30:334-340. (Pubitemid 38019394)
39. Mattila K, Vesanen M, Valtonen V, et al. Effect of treating periodontitis on C-reactive protein levels: A pilot study. BMC Infect Dis 2002;2:30.
40. Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N, Yoshie H. The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. J Periodontol 2010;81:1118-1123.
41. Pankow JS, Folsom AR, Cushman M, et al. Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study. Atherosclerosis 2001;154:681-689. (Pubitemid 32232166)
42. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999;100:793-798. (Pubitemid 29398875)
43. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E; for the Cholesterol and Recurrent Events (CARE) Investigators. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999;100:230-235. (Pubitemid 29340127)
44. Torgano G, Cosentini R, Mandelli C, et al. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation 1999;99: 1555-1559. (Pubitemid 29152921)
45. Stone AF, Mendall MA, Kaski JC, et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation 2002;106:1219-1223. (Pubitemid 34988639)
46. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-407. (Pubitemid 27329411)
47. Kannel WB. Influence of fibrinogen on cardiovascular disease. Drugs 1997;54(Suppl. 3):32-40. (Pubitemid 27488853)
48. Meade TW. Fibrinogen and cardiovascular disease. J Clin Pathol 1997;50:13-15. (Pubitemid 27060197)
49. Vaisanen S, Rauramaa R, Penttila I, et al. Variation in plasma fibrinogen over one year: Relationships with genetic polymorphisms and non-genetic factors. Thromb Haemost 1997;77:884-889. (Pubitemid 27239109)
50. D'Aiuto F, Nibali L, Mohamed-Ali V, Vallance P, Tonetti MS. Periodontal therapy: A novel nondrug- induced experimental model to study human inflammation. J Periodontal Res 2004;39:294-299. (Pubitemid 39278527)
51. Minassian C, D'Aiuto F, Hingorani AD, Smeeth L. Invasive dental treatment and risk for vascular events: A self-controlled case series. Ann Intern Med 2010; 153:499-506.